text.skipToContent text.skipToNavigation
  • Cross.svg
    Extensive product ranges
Calling 01685 846666

Menquadfi meningococcal (group A,C,W,Y) conjugate vaccine 0.5ml solution for injection POM X 1

ID:J1509 , 4195368
Pharmaceutical Product
Order from supplier within 7 working days.

Important Notice: Pharma products are sold and shipped exclusively to registered medical professionals at verified medical premises. 

Non-approved buyers: Complete our Online POM Form, and we will notify you once your account is Pharma approved.


What is Medquadfi?:
 
MenQuadfiTM is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.

 

What is Menquafi used for?:

 

MenQuadfi is designed to help protect individuals aged 12 months and older against IMD caused by serogroups A, C, W and Y. It is the only MenACWY conjugate vaccine in Europe available in a fully liquid formulation.9,10 This can potentially save time and reduce reconstitution errors.

 

MenQuadfi uses a tetanus toxoid carrier protein, which is able to impact the T-cell dependent immune system.

 

In clinical trials, the safety of MenQuadfi was shown to be similar to comparator vaccines.

 

A MenACWY certificate will be provided on ordering MenQuadfi.


Neisseria meningitidis bacteria (also called meningococci) can be passed from person to person and can cause serious and sometimes life-threatening infections, such as:


• Meningitis – an inflammation of the tissues that surround the brain and spinal cord;
• Septicemia – an infection of the blood 

 

Patient info leaflet link:

 

pil.12818.pdf

Specs
Reviews
Downloads